NRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

Go back to NRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
(NASDAQ: NRXP) Delayed: 3.52 +0.03 (0.86%)
Previous Close $3.49    52 Week High
Open $3.50    52 Week Low
Day High $3.54    P/E N/A 
Day Low $3.42    EPS
Volume 553,561